Immunovant Inc
IMVT
Equity
ISIN null / Valor 51661055
NASDAQ (2026-09-11)
USD 37.36-1.94%
Immunovant Inc
UMushroom community rating:
About company
Immunovant Inc. is a biopharmaceutical company developing therapies that target the neonatal Fc receptor (FcRn) to treat autoimmune and related diseases.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
122%1Y
65.7%3Y
333%5Y
Performance
57.7%1Y
66.6%3Y
65.7%5Y
Volatility
7717 M
Market cap (USD)
1,031,890
Daily traded volume (Shares)
24.55 / 23.88
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
